Daniel A. Benamran

Rue Gabrielle Perret Gentil 4
Geneve, GE 1205, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 72 publications

Quantitative Diffusion-weighted Imaging in Eosinophilic Solid and Cystic Renal Cell Carcinoma.

Quantitative Diffusion-weighted Imaging in Eosinophilic Solid and Cystic Renal Cell Carcinoma.

Journal: Radiology. Imaging cancer

Published: May 08, 2026

ISUP 2 prostate cancer with suspicion of extraprostatic extension on MRI: Prostatectomy results and oncologic outcomes.

ISUP 2 prostate cancer with suspicion of extraprostatic extension on MRI: Prostatectomy results and oncologic outcomes.

Journal: Urologic oncology

Published: October 06, 2025

Modeling CAF-tumor interactions to overcome therapy resistance.

Modeling CAF-tumor interactions to overcome therapy resistance.

Journal: Journal of experimental & clinical cancer research : CR

Published: July 24, 2025

Rational Design of Non-Toxic Multidrug Combinations Demonstrates Durable and Hypoxia-Enhanced Efficacy Against Renal Cell Carcinoma.

Rational Design of Non-Toxic Multidrug Combinations Demonstrates Durable and Hypoxia-Enhanced Efficacy Against Renal Cell Carcinoma.

Journal: Pharmaceutics

Published: July 22, 2025

Leveraging multi-organ models for drug combination therapy safety.

Leveraging multi-organ models for drug combination therapy safety.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: May 21, 2025

Urological cancers in Geneva : epidemiology and diagnosis, where do we stand?

Urological cancers in Geneva : epidemiology and diagnosis, where do we stand?

Journal: Revue medicale suisse

Published: November 28, 2024

Generation and maintenance of kidney and kidney cancer organoids from patient-derived material for drug development and precision oncology.

Generation and maintenance of kidney and kidney cancer organoids from patient-derived material for drug development and precision oncology.

Journal: Molecular therapy. Methods & clinical development

Published: August 01, 2024

Refining clinically relevant cut-offs of prostate specific antigen density for risk stratification in patients with PI-RADS 3 lesions.

Refining clinically relevant cut-offs of prostate specific antigen density for risk stratification in patients with PI-RADS 3 lesions.

Journal: Prostate cancer and prostatic diseases

Published: May 19, 2024

[68Ga]Ga-PSMA-11 PET and Prostate Cancer Bone Metastases: Diagnostic Performance of Available Standardized Criteria.

[68Ga]Ga-PSMA-11 PET and Prostate Cancer Bone Metastases: Diagnostic Performance of Available Standardized Criteria.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: April 15, 2024

Transrectal versus transperineal prostate fusion biopsy: a pair-matched analysis to evaluate accuracy and complications.

Transrectal versus transperineal prostate fusion biopsy: a pair-matched analysis to evaluate accuracy and complications.

Journal: World journal of urology

Published: April 08, 2024

External validation and comparison of magnetic resonance imaging-based risk prediction models for prostate biopsy stratification.

External validation and comparison of magnetic resonance imaging-based risk prediction models for prostate biopsy stratification.

Journal: World journal of urology

Published: April 04, 2024

Mast-cell derived nerve growth factor drives ILC2 pro-tumoral functions in bladder cancer.

Mast-cell derived nerve growth factor drives ILC2 pro-tumoral functions in bladder cancer.

Journal: Nature communications

Published: February 19, 2024

Showing 1-12 of 72

Last Updated: 09/26/2026